UK Drugmaker Builds 200-mln-dollar Facility in Jiangsu
    2012-01-05 13:53:01     Xinhua      Web Editor: Sun
British drugmaker AstraZeneca has broken ground on its planned 200-million-dollar manufacturing facility in east Jiangsu Province, local authorities said Thursday.
Audio

British drugmaker AstraZeneca has broken ground on its planned 200-million-dollar manufacturing facility in east Jiangsu Province, local authorities said Thursday.

Construction of the facility, which the company said is its largest ever investment in a single manufacturing facility globally, started Wednesday at China Medical City - a medical high-tech zone in the city of Taizhou, said an official with the zone's management office.

The new facility will produce both intravenous and oral solid medicines for the company's growing business in China, according to a statement from AstraZeneca - Britain's second biggest drug maker.

Construction of the site is scheduled to be completed at the end of 2013 and annual sales revenue is expected to reach 6 billion yuan (950 million U.S. dollars) after it commences operation.

The company's business in China has grown rapidly since it first established a presence in 1993.

"We believe the Chinese government's focus on the healthcare reform, its investment in improving the country's healthcare infrastructure, and its expansion of insurance coverage will continue to drive growth and demand for high-quality medicine over the long term," said David Smith, executive vice-president in charge of the London-based drugmaker's global operations.

AstraZeneca will also establish one of its three global hubs in Shanghai, according to Smith.

Share

                  


CRIENGLISH.com claims the copyright of all material and information produced originally by our staff. All rights reserved. Reproduction of text for non-commercial purposes only is permitted provided that both the source and author are acknowledged and a notifying email is sent to us.

CRIENGLISH.com holds neither liability nor responsibility for materials attributed to any other source. Such information is provided as reportage and dissemination of information but does not necessarily reflect the opinion of or endorsement by CRI.

 
Audio Reports more »
Biz Life more »
Policy more »
Markets more »

• China
China News
Chinese Press
Diplomatic
Society
Gallery
• World
Asia-Pacific
Europe
Americas
Middle East
Africa
• Video
Traveller
Culture Heritage
Beyond Stardom
Dynamic China

Life 360
Panoramic Sports
• Radio
Highlights
Livecast
Ways to Listen
• Business
Audio
Markets
Editor's Choice
Biz Photo
Special Coverage
• Travel
Destinations
Editor's Pick
What's in
On the Road
• Showbiz
Chinese Films
Music & Stage
Art & Literature
Video
Photo Gallery
Special Coverage
• Language Learning
Ask Pingping and Jules
Chinese Studio
Elementary Chinese
Pop Charts
English News
English Snippets